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Abstract 
As its integrity is essential for cognitive performances, it is surprising that there are no adequate studies in terms 
of the corpus callosum changes in diabetic patients. Consequently, the aim of this paper is to show how corpus 
callosum craniocaudal dimensions are changed by diabetes mellitus. 
The study was designed as a retrospective investigation. The study group included 50 patients who had suffered 
from diabetes mellitus for at least 10 years and were admitted for brain magnetic resonance imaging between the 
years 2011 and 2014 suffering from headaches. From cranial MR images the craniocaudal  length of the corpus 
callosum was measured from the lowest parts of the genu, corpus and splenium on the midline of the corpus 
callosum on T2-weighted MR images. 
According to the analysis, disease status has a high effect on the corpus, genu and splenium heights of the 
corpus callosum (t(99) =5.66 – 4.99 – 6.06 p<0.05). Before the age of 71, all the parts of the corpus callosum 
heights are relatively low in diabetes mellitus-diseased subjects when compared to non-diseased ones. Before 
71, age has no effect on corpus callosum heights. After 71, both age and diabetes mellitus have an effect on the 
heights of the corpus part of the corpus callosum. 
------------------------------------------------------------------------ 
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Before the age of 71, corpus callosum height reduction may contribute to a cognitive decline in patients with 
diabetes mellitus. After 71, both age and diabetes mellitus have an effect on the heights of the corpus part of the 
corpus callosum. So after this age, cognitive decline may be even more pronounced. 
As its integrity is essential for cognitive performances it is surprising that there are no adequate studies in terms 
of the corpus callosum changes in diabetic patients. According to the analysis in our study, disease status has a 
high effect on the corpus, genu and splenium heights of the corpus callosum. This study needs to be followed 
with a new study that investigates cognitive performance changes with corpus callosum height reduction in 
patients with diabetes mellitus.   
Keywords: corpus callosum; craniocaudal dimensions ; diabetes mellitus. 
1. Introduction  
As its integrity is essential for cognitive performances, it is surprising that there are no adequate studies in terms 
of the corpus callosum changes in diabetic patients. It is not known exactly whether diabetes mellitus has any 
effect on corpus callosum heights. Consequently, this paper shows how corpus callosum craniocaudal 
dimensions are changed by diabetes mellitus. 
2. Material and Methods  
The study was designed as a retrospective investigation. In our study, individuals were subdivided into four 
groups according to age (under 50, 51–60, 61–70 and over 70), two groups according to gender (58 males and 
41 females) and two groups depending on whether they were diseased or not. The study group included 50 
patients who had suffered from diabetes mellitus for at least 10 years and were admitted for brain magnetic 
resonance imaging between the years 2011 and 2014 suffering from headaches. In the study, a control group 
was formed with 49 individuals who were admitted for brain magnetic resonance imaging (MRI) suffering only 
from a headache and without any additional disease. No patient satisfied the criteria for dementia. All had 
normal laboratory test results for vitamin B12 levels and thyroid hormone levels. A GE 1.5 Tesla MR scanner 
(General Electric Magnetom Essenza Syngo MR) in Bilecik State Hospital Radiology Department was used. T1-
weighted sagittal and axial images were obtained with the use of a spin echo pulse sequence. Axial proton-
weighted and T2-weighted images were also obtained with spin echo pulse sequences. The slice thickness was 3 
mm for sagittal images and 5 mm for axial images. From cranial MR images the craniocaudal length of the 
corpus callosum was measured from the lowest parts of the genu, corpus and splenium on the midline of the 
corpus callosum on T2-weighted MR images. 
3. Results 
In statistical analysis [Table 1]: 
Approximately 15% of the subjects examined were 50 years and under, about 32% were in the age range 51–60, 
23% were in the 61–70 age range and 29% were aged 71 years and above. About 59% of the respondents were 
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male subjects and 41% were females. 
Table 1: Descriptive statistics 
Age groups N  % 
50 and under 15 15.2 
51–60  32 32.3 
61–70  23 23.2 
71 and above 29 29.3 
Total 99 100.0 
   
 Diseased N  % 
no 50 50.5 
yes 49 49.5 
Total 99 100.0 
   
 Gender N  % 
male 58 58.6 
female 41 41.4 
Total 99 100.0 
 
1. The correlation between disease status and corpus callosum height 
In the study an independent t-test was used for the purpose of determining whether there was an effect of disease 
status on the measurement of corpus callosum height. The results obtained are summarized in the table below 
[Table 2]. 
Table 2: Disease status and measurements 
  Disease status n Mean Std. 
Deviation 
t P 
Genu yes 49 49.3469 26.31821 4.99718 0.00 
no 50 77.9000 30.34647 
Corpus yes 49 27.4694 11.16748 5.66607 0.00 
no 50 44.3400 17.66769 
Splenium yes 49 61.3673 34.44966 6.06937 0.00 
no 50 98.2200 25.36935 
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According to the analysis, disease status has a high effect on the corpus, genu and splenium heights of the 
corpus callosum (t(99) =5.66 – 4.99 – 6.06 p<0.05). Corpus, genu and splenium heights were relatively low in 
diseased subjects when compared to non-diseased subjects. In contrast, corpus, genu and splenium 
measurements were very high in non-diseased persons compared to diseased individuals. 
2. The effect of gender on genu, corpus and splenium heights in corpus callosum analysis 
For the purpose of determining whether there was an effect of gender on the genu, corpus and splenium heights 
of the corpus callosum, an independent t-test was used. The results are summarized in the following table [Table 
3]. 
Table 3: The effect of gender on genu, corpus and splenium heights 
  gender n Mean Std. Deviation T P 
Genu male 58 68.4483 31.11956 1.76552 .08062 
female 41 57.1463 31.73292 
Corpus male 58 38.3793 16.51244 1.67861 .09645 
female 41 32.6098 17.30878 
Splenium male 58 89.2759 33.02195 3.26670 .00150 
female 41 66.8293 34.58822 
 
The analysis determined whether the gender of the subjects had an effecton the heights of the genu, corpus and 
splenium parts of the corpus callosum (t(99) =1.679 – 1.765 p>0.05). There was no effect of gender on the genu 
and corpus heights of the corpus callosum. But splenium measurements were found to be different according to 
gender (t(99) =3.266 p<0.05). The splenium measurements were lower in female individuals than in males.  
3. Does gender have an effect on the genu, corpus and splenium heights of the corpus callosum in diseased 
individuals?  
To determine whether gender and disease status have an effect on the heights of the genu, corpus and splenium 
of the corpus callosum, two-way analysis of variance (MANOVA) was used. The results are summarized in the 
following table [Table 4]. 
According to the results, in diseased individuals gender had no effect on the genu and corpus heights of the 
corpus callosum (F=0.53 – 1.53, p>0.05). The genu and corpus heights of female and male diseased individuals 
were quite similar. But the gender of diseased individuals had an effect on the splenium heights of the corpus 
callosum (F=2.53, p<0.05). 
Bonferroni pairwise comparisons revealed that the average height of the splenium of the corpus callosum in 
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female diseased subjects was lower than that in male subjects (p <0.05). 
Table 4: The effect of gender on genu, corpus and splenium heights in diseased individuals 
Heights Gender Disease status Mean Std. Deviation n F P 
Genu 
male 
no 81.5833 27.18337 36 
0.53 0.47 
yes 46.9545 24.84519 22 
Total 68.4483 31.11956 58 
female 
no 68.4286 36.70823 14 
yes 51.2963 27.77356 27 
Total 57.1463 31.73292 41 
Corpus 
male 
no 45.1944 16.32845 36 
1.53 0.68 
yes 27.2273 9.26299 22 
Total 38.3793 16.51244 58 
female 
no 42.1429 21.24892 14 
yes 27.6667 12.68251 27 
Total 32.6098 17.30878 41 
Splenium 
male 
no 100.5833 29.27444 36 
2.53 0.05 
yes 70.7727 30.88062 22 
Total 89.2759 33.02195 58 
female 
no 92.1429 7.96007 14 
yes 53.7037 35.84563 27 
Total 66.8293 34.58822 41 
 
4. Does age have an effect on the genu, corpus and splenium heights of the corpus callosum? 
To determine whether age has an effect on the heights of the genu, corpus and splenium of the corpus callosum, 
one-way analysis of variance (ANOVA) was used. The results are summarized in the following table [Table 5]. 
Genu and splenium measurements seemed to be quite indistinguishable by age groups (F = 1.78 – 1.495, p 
>0.05). Corpus measurements were found to vary by age groups (F = 4.200, p >0.05). To investigate the cause 
of the difference, post hoc analysis (Sidak test) was performed and the corpus measured values were found to be 
lower in the 71 and above group than in the other age groups (p <0.05). 
When we evaluate the results, 
Disease status had a high effect on the corpus, genu and splenium heights of the corpus callosum (t(99) = 5.66 – 
4.99 – 6.06, p <0.05). Corpus, genu and splenium heights were lower in diseased subjects than in non-diseased 
subjects. 
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Table 5: The effect of age on genu, corpus and splenium heights 
 
Age groups n mean Std deviation   F    P  
 
Genu 
50 and under  15 62.400 33.449 
1.781 0.156 
 
51–60  32 72.000 33.819 
 
61–70 23 65.913 31.704 
 
71 and above 29 53.690 26.770 
 
Total 99 63.768 31.711 
 
Corpus  
50 and under  15 34.733 14.844 
4.200 0.008 
 
51–60 32 43.063 16.932 
 
61–70 23 37.783 15.395 
 
71 and above 29 29.483 16.713 
 
Total 99 35.990 17.001 
 
Splenium 
50 and under  15 72.333 41.491 
1.495 0.221 
 
51–60 32 90.344 32.375 
 
61–70 23 73.174 41.787 
 
71 and above 29 77.897 27.772 
 
Total 99 79.980 35.299 
 
 
It was determined whether the gender of the subjects had an effect on the heights of the genu, corpus and 
splenium parts of the corpus callosum (t(99) = 1.679 – 1,765, p >0.05). There was no effect of gender on the genu 
and corpus heights of the corpus callosum. But splenium measurements were found to be different according to 
gender (t(99) = 3.266, p <0.05). The splenium measurements were lower in female individuals than in males.  
The gender of diseased individuals had an effect on the splenium heights of the corpus callosum (F = 2.53, p 
<0.05). The average height of the splenium of the corpus callosum in female diseased subjects was lower than 
that in male subjects (p <0.05). 
Genu and splenium measurements seemed to be quite indistinguishable by age groups (F = 1.78 – 1.495, p 
>0.05). Corpus measured values were found to be lower in the 71 and above group than in the other age 
groups(p <0.05). 
We see that before the age of 71, the heights of all the parts of the corpus callosum (genu, corpus and splenium) 
are lower in diabetes mellitus diseased subjects than in non-diseased ones. Before 71, age has no effect on 
corpus callosum heights. We know that the corpus callosum is an important part of the brain for cognitive 
functions. So as a result, before the age of 71, corpus callosum height reduction may contribute to cognitive 
decline in patients with diabetes mellitus. After 71, both age and diabetes mellitus have an effect on the heights 
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of the corpus part of the corpus callosum. So after this age, cognitive decline may be even more pronounced. In 
healthy adults, splenium heights are lower in women than in men, and therefore cognitive dysfunction may be 
more prominent in women than in men due to the addition of disease-related corpus callosum height reduction. 
4. Discussion 
The principal interhemispheric commissure is the corpus callosum (CC). The mature CC contains myelinated 
(70%) and unmyelinated fibers (30%), glial cells (astrocytes and oligodendrocytes) and neurons. The human CC 
has been divided into five anatomical regions, which include, from front to back, the genu, the rostrum, the body 
and trunk – often subdivided into anterior, middle and posterior body – the isthmus and the splenium. There are 
no clear borders between regions. The different callosal regions have different fiber compositions. Large-
diameter fibres have been described in the posterior part of the splenium and in the body,  where 
interhemispheric sensory fibers cross the commissure and exchange information at high speed, whereas small 
fibers mainly connecting association cortical areas are found in the rostrum, genu and anterior body [1,2]. The 
anterior half of the human CC (genu, rostrum and body) contains fibers interconnecting frontal association 
cortical areas. The isthmus mostly contains primary motor, somatosensory and auditory fibers. In the splenium, 
primary visual and association temporo-occipital and parietal commissural fibers are mixed, forming a single 
segment with the hippocampal commissure through which parahippocampal fibers cross [3].  
Its known functions include: interhemispheric exchange of information, integration of inputs reaching one or 
both hemispheres, facilitation of some cortical activities and inhibition of cortical functions [4,5]. It has recently 
been shown that the size of the human CC positively correlates with intelligence and that its integrity is essential 
for cognitive performances; thus CC resection and microstructural or developmental alterations are often 
associated with cognitive decline [6].  
Corpus callosum volume changes are a curiosity in non-operated individuals, because infarcts of the corpus 
callosum are not common and are attributed to a rich blood supply from three main arterial systems: the anterior 
communicating artery, the pericallosal artery and the posterior pericallosal artery [7]. The pericallosal branch of 
the anterior cerebral artery is most often the main vascular supply to the body. The subcallosal and medial 
callosal arteries, branches of the anterior communicating artery, provide the main supply for the anterior portion 
of the corpus callosum. The posterior pericallosal artery, a branch of the posterior cerebral artery, supplies the 
splenium.  
In what circumstances are corpus callosum dimensions affected? Chrysikopoulos et al. suggest that ısolated 
infarcts of the anterior and posterior cerebral arteries are uncommon, accounting for 12% of all infarcts, and 
when present are found in conjunction with generalized atherosclerotic disease [7]. Chrysikopoulos et al. found 
that the splenium of the corpus callosum was affected more often than were the body and genu. All of the 
patients in David L. Kasow et al.’s  series had long histories of hypertension and three of the five patients had 
insulin-dependent diabetes mellitus, predisposing them to generalized atherosclerosis. In David L. Kasow et 
al.’s series, all of the lesions involved the genu, body or both, whereas none involved the splenium. The 
difference in the location of the infarcts in their study, as compared with that reported by Chrysikopoulos et al., 
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may be due to the difference in the patient population; i.e. patients with diabetes and hypertension develop 
generalized atherosclerosis, which in turn increases the incidence of anterior circulation infarction.  
These studies have suggested that patients with diabetes and hypertension develop generalized atherosclerosis 
resulting in changes in size of the corpus callosum. Diabetes mellitus is a complex metabolic disease that can 
have devastating effects on multiple organs in the body. Diabetes is the leading cause of end-stage renal disease 
and is also a common cause of vision loss, neuropathy and cardiovascular disease. A less addressed and not as 
well recognized complication of diabetes is cognitive dysfunction. Cognitive deficits in persons with diabetes 
mainly affect the areas of psychomotor efficiency, attention, learning and memory, mental flexibility and speed, 
and executive function [8,9]. Patients with type 1 and type 2 diabetes mellitus have been found to have cognitive 
deficits that can be attributed to their disease. The exact pathophysiology of cognitive dysfunction in diabetes is 
not completely understood but it is likely that hyperglycaemia, vascular disease, hypoglycaemia and insulin 
resistance play significant roles.  
However, the determinants of the accelerated cognitive decline in DM are less clear. The most studied 
hypothesis proposes that the primary cause of the association may be linked to diabetic vascular disease and 
inadequate cerebral circulation, with subsequent silent ischaemic damage induced by diabetes. Hyperglycaemia 
and hyperinsulinaemia may lead to widespread brain microangiopathy by inducing hyperphosphorylation and 
amyloid oligomerization [10].  
5. Conclusion 
As its integrity is essential for cognitive performances it is surprising that there are no adequate studies in terms 
of the corpus callosum changes in diabetic patients. According to the analysis in our study, disease status has a 
high effect on the corpus, genu and splenium heights of the corpus callosum. This study needs to be followed 
with a new study that investigates cognitive performance changes with corpus callosum height reduction in 
patients with diabetes mellitus.   
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